# Qishenyiqi for Ventricular Remodeling After Myocardial Infarction

> **NCT06699407** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Qilu Hospital of Shandong University** · enrollment: 210 (estimated)

## Conditions studied

- Chronic Stable Heart Failure

## Interventions

- **DRUG:** Qishenyiqi dripping pills
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06699407
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11-20
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2024-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06699407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06699407, "Qishenyiqi for Ventricular Remodeling After Myocardial Infarction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06699407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*